title: Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts.
authors.affiliation: Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.
authors.forename: Ran
authors.initials: R
authors.lastname: Tao
authors.forename: Kristine
authors.initials: K
authors.lastname: Ruppert
authors.forename: Ruy J
authors.initials: RJ
authors.lastname: Cruz
authors.forename: Shahid M
authors.initials: SM
authors.lastname: Malik
authors.forename: Obaid
authors.initials: O
authors.lastname: Shaikh
authors.forename: Jawad
authors.initials: J
authors.lastname: Ahmad
authors.forename: Andrea
authors.initials: A
authors.lastname: DiMartini
authors.forename: Abhinav
authors.initials: A
authors.lastname: Humar
authors.forename: Paulo A
authors.initials: PA
authors.lastname: Fontes
authors.forename: Michael E
authors.initials: ME
authors.lastname: de Vera
mesh_terms: D001706:Biopsy; D001926:Brain Death; D016022:Case-Control Studies; D005260:Female; D006084:Graft Rejection / Q000503:physiopathology / Q000821:virology; D006085:Graft Survival; D016174:Hepacivirus; D006526:Hepatitis C / Q000209:etiology* / Q000503:physiopathology / Q000601:surgery*; D006801:Humans; D007165:Immunosuppression Therapy; D008099:Liver / Q000473:pathology / Q000503:physiopathology / Q000601:surgery / Q000821:virology; D016031:Liver Transplantation / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D012008:Recurrence; D012307:Risk Factors; D014019:Tissue Donors; D014184:Transplantation, Homologous; D016896:Treatment Outcome